<?xml version="1.0" encoding="ISO-8859-1"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level2.owl#" xmlns="http://www.phidias.us/biopax#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:daml="http://www.daml.org/2001/03/daml+oil#" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <owl:Ontology rdf:about="">
    <owl:imports rdf:resource="http://www.biopax.org/release/biopax-level2.owl"/>
  </owl:Ontology>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Cell_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Complex">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Complex</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Enzyme">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enzyme</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Eukaryotic_cell_or_cell_component">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eukaryotic cell or cell component</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Microbe-host_cell_complex">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Microbe-host cell complex</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Microorganism_or_its_component">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Microorganism or its component</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Other">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Other</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Other_--_ion">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Other -- ion</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Pathway_or_action">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway or action</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Protein">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Protein_or_gene">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein or gene</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Protein_or_gene_complex">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein or gene complex</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Protein_or_protein_complex">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein or protein complex</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Bacterial_membrane_or_virus_envelope">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bacterial membrane or virus envelope</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Cell_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Cytoplasm">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cytoplasm</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Eukaryotic_cell_or_cell_component">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eukaryotic cell or cell component</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Extracellular">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Extracellular</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Golgi">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Golgi</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Golgi_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Golgi membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Intercellular">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Intercellular</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Intracellular">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Intracellular</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Mitochondria">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mitochondria</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Nucleocapsid/Cytoplasm">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nucleocapsid/Cytoplasm</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Cell_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Cell membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Endoplasmic_reticulum">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Endoplasmic reticulum</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_ER">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- ER</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Golgi">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Golgi</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Golgi_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Golgi membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Nucleus">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Nucleus</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Phagolysosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Phagolysosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Phagosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Phagosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Ribosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Ribosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Other">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Other</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Phagolysosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phagolysosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Phagosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phagosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Chaperone">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chaperone</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Defense,_immunity_protein">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Defense, immunity protein</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Enzyme">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enzyme</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Enzyme_activator">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enzyme activator</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Enzyme_inhibitor">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enzyme inhibitor</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Genomic_S_segment">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Genomic S segment</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Infection">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Infection</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Ligand_binding_or_carrier">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ligand binding or carrier</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Motor">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Motor</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Nucleic_acid_binding">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nucleic acid binding</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Other">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Other</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Signal_transducer">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Signal transducer</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Toxicity">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Toxicity</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Transcription_factor_binding">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Transcription factor binding</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Transcription_regulation">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Transcription regulation</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Transporter">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Transporter</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Unknown">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Unknown</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:evidence rdf:ID="evidence_IC">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IC">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IC</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred by Curator</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IDA">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IDA">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IDA</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Direct Assay</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IEA">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IEA">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IEA</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Electronic Annotation</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IEP">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IEP">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IEP</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Expression Pattern</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IGI">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IGI">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IGI</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Genetic Interaction</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IMP">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IMP">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IMP</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Mutant Phenotype</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IPI">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IPI">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IPI</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Physical Interaction</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_ISS">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_ISS">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ISS</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Sequence or Structural Similarity</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_NAS">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_NAS">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NAS</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Non-traceable Author Statement</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_ND">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_ND">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ND</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">No biological Data available</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_RCA">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_RCA">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">RCA</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">inferred from Reviewed Computational Analysis</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_TAS">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_TAS">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">TAS</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Traceable Author Statement</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_NR">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_NR">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NR</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Not Recorded</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:publicationXref rdf:ID="reference5374">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Volchkov VE, Volchkova VA, Stroher U, Becker S, Dolnik O, Cieplik M, Garten W, Klenk HD, Feldmann H</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proteolytic processing of Marburg virus glycoprotein</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">20001</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10683320</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5380">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bavari S, Bosio CM, Wiegand E, Ruthel G, Will AB, Geisbert TW, Hevey M, Schmaljohn C, Schmaljohn A, Aman MJ</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The Journal of experimental medicine</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">20024</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11877482</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5381">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Becker S, Klenk HD, Muhlberger E</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Intracellular transport and processing of the Marburg virus surface protein in vertebrate and insect cells</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">19961</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8918541</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5375">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sanger C, Muhlberger E, Ryabchikova E, Kolesnikova L, Klenk HD, Becker S</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sorting of Marburg virus surface protein and virus release take place at opposite surfaces of infected polarized epithelial cells</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2001</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11152500</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5382">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Becker S and Muhlberger E</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Marburg and Ebola viruses</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Co- and posttranslational modifications and functions of Marburg virus proteins.</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1999</bp:YEAR>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5379">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Modrof J, Moritz C, Kolesnikova L, Konakova T, Hartlieb B, Randolf A, Muhlberger E, Becker S</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phosphorylation of Marburg virus VP30 at serines 40 and 42 is critical for its interaction with NP inclusions</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">200115</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11504552</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5370">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kolesnikova L, Bugany H, Klenk HD, Becker S</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2002</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11799178</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5378">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Huang Y, Xu L, Sun Y, Nabel GJ</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular cell</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2002</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12191476</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5384">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Peters CJ, Sanchez A, Rollin PE, Ksiazek TG, and Murphy FA</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Field's Virology Third Edition Volume 1</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Filoviridae:  Marburg and Ebola Viruses</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1996</bp:YEAR>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5371">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sanger C, Muhlberger E, Lotfering B, Klenk HD, Becker S</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The Marburg virus surface protein GP is phosphorylated at its ectodomain</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">200230</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12033762</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5369">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Muhlberger E, Weik M, Volchkov VE, Klenk HD, Becker S</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1999</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">9971816</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5373">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kolesnikova L, Muhlberger E, Ryabchikova E, Becker S</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2000</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10729166</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5372">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lotfering B, Muhlberger E, Tamura T, Klenk HD, Becker S</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The nucleoprotein of Marburg virus is target for multiple cellular kinases</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">19991</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10049821</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5383">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Feldmann H and Kiley MP</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Marburg and Ebola viruses</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Classification, structure, and replication of filoviruses</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1999</bp:YEAR>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5377">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bray M, Paragas J</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Antiviral research</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Experimental therapy of filovirus infections</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2002</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11888653</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5376">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Feldmann H, Volchkov VE, Volchkova VA, Stroher U, Klenk HD</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The Journal of general virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biosynthesis and role of filoviral glycoproteins</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2001</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11714958</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:physicalEntityParticipant rdf:ID="bioobject_392">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GP</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Ligand binding or carrier.
Cell entry is presumably mediated by GP (Feldmann and Kiley, 1999).  Each molecule in the trimeric GP is composed of an external segment, GP1, which is linked by a disulfide bond to a transmembrane unit, GP2 (Bray and Paragas, 2002).  Several groups have demonstrated independently that the transmembrane glycoprotein of filoviruses mediates receptor binding and subsequent fusion with susceptible cells (Feldmann et al., 2001).(<a href="#reference5376">Feldmann et al., 2001</a>)(<a href="#reference5377">Bray et al., 2002</a>)(<a href="#reference5383">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_393">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell membrane receptor</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cell_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Ligand binding or carrier.
There is evidence that Marburg virus uses the asialoglycoprotein receptor to infect hepatocytes.  For Ebola virus, it was suggested that integrins, especially the Beta1 group, might interact with the glycoprotein and perhaps be involved in entry into the cells.  More recent studies indicate that the folate receptor-alpha serves as a cofactor for cellular entry by Marburg and Ebola viruses (Feldmann et al., 2001).(<a href="#reference5376">Feldmann et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_394">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Attached virus</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cell_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Replication begins with the attachment of the virion to a cell-surface receptor, which may be the alpha-folate receptor.  After binding, the virus enters the cell through receptor-mediated endocytosis  (Bray and Paragas, 2002).(<a href="#reference5377">Bray et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_395">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fused virus</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Fusion of the viral envelope with the cellular endosomal membrane releases the RNP into the cytoplasm  (Bray and Paragas, 2002).  Fusion activity has never been demonstrated experimentally.  Early post-infection filovirus particles are associated with coated pits along the plasma membrane, indicating endocytosis as a possible mechanism for entry (Feldmann et al., 2001).  Recently, it was shown that the coiled-coil motif of GP2 plays an important role in facilitating the entry of Ebola virus. For Marburg virus, a similar putative fusion domain can be found at a distance of 91 amino acids from the cleavage site (Feldmann et al., 2001).(<a href="#reference5377">Bray et al., 2002</a>)(<a href="#reference5376">Feldmann et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_396">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Uncoated virus</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cell_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Virus entry is probably receptor-mediated followed by fusion and uncoating, two steps which have not yet been examined (Feldmann and Kiley, 1999).(<a href="#reference5383">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_397">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Replication complex</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The ribonucleoprotein (RNP) complex in the virion core, made up of the RNA genome and its encapsidating proteins, VP30 and NP, is linked by matrix proteins to the glycoprotein (GP)-bearing lipid envelope derived from the host cell membrane (Bray and Paragas, 2002).  Two other proteins present in lower copy number within the virion, VP35 and the RNA-dependent RNA polymerase, or L protein, associate with VP30 and NP to make up the Ebola replication complex (Bray and Paragas, 2002). Genomes of filoviruses consist of a single negative-stranded linear RNA molecule.  The RNA is noninfectious, does not contain a poly A tail, and upon entry into the cytoplasm of host cells is transcribed to generated polyadenylated subgenomic mRNA species (Feldmann and Kiley, 1999).  The Marburg virus RNA is of negative polarity and encodes seven structural proteins, whose genes are organized in the following linear order: 3' NP, VP35, VP40, GP, VP30, VP24, L 5' (Lotfering et al., 1999).  Viral reproduction takes place in the cytoplasm (Kolesnikova et al., 2000).(<a href="#reference5377">Bray et al., 2002</a>)(<a href="#reference5383">Feldmann2</a>)(<a href="#reference5372">Lotfering et al., 1999</a>)(<a href="#reference5373">Kolesnikova et al., 2000</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_398">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NP mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Transcription by the viral RNA-dependent RNA polymerase initiates at the 3' end of the genome, resulting in synthesis of a leader RNA and seven polyadenylated mRNAs. Accumulation of the first two proteins encoded at the 3' end of the genome (NP and VP35) in some way triggers a switch to production of full-length, positive-sense `antigenomes', which serve, in turn, as templates for genome synthesis (Bray and Paragas, 2002).  The nucleoprotein (NP) is encoded by gene 1 at the extreme 3' end of the linear unsegmented RNA genome (Feldmann and Kiley, 1999).(<a href="#reference5377">Bray et al., 2002</a>)(<a href="#reference5383">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_399">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP35 mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Transcription by the viral RNA-dependent RNA polymerase initiates at the 3' end of the genome, resulting in synthesis of a leader RNA and seven polyadenylated mRNAs. Accumulation of the first two proteins encoded at the 3' end of the genome (NP and VP35) in some way triggers a switch to production of full-length, positive-sense `antigenomes', which serve, in turn, as templates for genome synthesis (Bray and Paragas, 2002).  Virion structural protein 35 (VP35) is encoded by gene 2 (Feldmann and Kiley, 1999).(<a href="#reference5377">Bray et al., 2002</a>)(<a href="#reference5383">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_400">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP40 mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Virion structural protein 40 (VP40) of filoviruses is encoded by gene 3 (Feldmann and Kiley, 1999).(<a href="#reference5383">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_401">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GP mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The glycoprotein of Marburg virus is transcribed from a single open reading frame (Muhlberger et al., 1999).  The GP gene is 2,844 nucleotides in length and encodes a protein of 681 amino acids. In contrast to Ebola virus where the virion-associated surface protein is only expressed after mRNA editing, Marburg virus GP is encoded by a single open reading frame (Sanger et al., 2001).  GP is encoded by gene 4 of the genome, is the only glycosylated structural protein of virions (Feldmann and Kiley, 1999).  The GP is the sole structural protein that makes up the virion surface spikes that mediate virus entry into susceptible host cells through receptor binding (Peters et al., 1996).(<a href="#reference5369">Muhlberger et al., 1999</a>)(<a href="#reference5371">Sanger et al., 2002</a>)(<a href="#reference5383">Feldmann2</a>)(<a href="#reference5384">Peters</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_402">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP30 mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Virion structural protein 30 (VP30) is encoded by gene 5 of filoviruses and is intimately associated with the RNP complex (Feldmann and Kiley, 1999).(<a href="#reference5383">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_403">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP24 mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Virion structural protein 24 (VP24) is encoded by gene 6 of filoviruses (Feldmann and Kiley, 1999).  Recent studies with Ebola virus have demonstrated that cotransfection of 293T cells with NP, VP35, and VP24 supported capsid formation, and omission of any one of these three genes abolished the effect, demonstrating that they are necessary and sufficient for viral particle formation (Huang et al., 2002).(<a href="#reference5383">Feldmann2</a>)(<a href="#reference5378">Huang et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_404">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">L mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The large (L) protein is encoded at the 5' end of the linear genome (Feldmann and Kiley, 1999).(<a href="#reference5383">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_405">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Positive sense genome</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Transcription by the viral RNA-dependent RNA polymerase initiates at the 3' end of the genome, resulting in synthesis of a leader RNA and seven polyadenylated mRNAs. Accumulation of the first two proteins encoded at the 3' end of the genome (NP and VP35) in some way triggers a switch to production of full-length, positive-sense `antigenomes', which serve, in turn, as templates for genome synthesis (Bray and Paragas, 2002).(<a href="#reference5377">Bray et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_406">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Negative sense genome</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Transcription by the viral RNA-dependent RNA polymerase initiates at the 3' end of the genome, resulting in synthesis of a leader RNA and seven polyadenylated mRNAs. Accumulation of the first two proteins encoded at the 3' end of the genome (NP and VP35) in some way triggers a switch to production of full-length, positive-sense `antigenomes', which serve, in turn, as templates for genome synthesis (Bray and Paragas, 2002).(<a href="#reference5377">Bray et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_407">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NP protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Three of the four nucleocapsid proteins, NP, VP35, and L, are sufficient to support replication and transcription of an Marburg virus-specific monocistronic minigenome (Muhlberger et al., 1999).  Encapsidation of the genomic RNA by the major nucleocapsid protein (NP) is presumed to be the first step in the assembly process of Marburg virus nucleocapsid (Kolesnikova et al., 2000).  Among the proteins of the Marburg virus nucleocapsid complex, only NP has the potential to self-assemble into large aggregates when it is expressed in the absence of other viral proteins (Kolesnikova et al., 2000).Transcription by the viral RNA-dependent RNA polymerase initiates at the 3' end of the genome, resulting in synthesis of a leader RNA and seven polyadenylated mRNAs. Accumulation of the first two proteins encoded at the 3' end of the genome (NP and VP35) in some way triggers a switch to production of full-length, positive-sense `antigenomes', which serve, in turn, as templates for genome synthesis (Bray and Paragas, 2002).NP is the primary structural protein associates with filovirus nucleocapsids (Peters et al., 1996).  Recent studies have demonstrated that cotransfection of 293T cells with NP, VP35, and VP24 supported capsid formation, and omission of any one of these three genes abolished the effect, demonstrating that they are necessary and sufficient for viral particle formation (Huang et al., 2002).(<a href="#reference5369">Muhlberger et al., 1999</a>)(<a href="#reference5373">Kolesnikova et al., 2000</a>)(<a href="#reference5377">Bray et al., 2002</a>)(<a href="#reference5384">Peters</a>)(<a href="#reference5378">Huang et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_408">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP35 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Three of the four nucleocapsid proteins, NP, VP35, and L, are sufficient to support replication and transcription of an Marburg virus-specific monocistronic minigenome (Muhlberger et al., 1999).  There is accumulating evidence that the filovirus VP35 is homologous to the P proteins of other Mononegavirales. First, it was observed previously that Ebola and Marburg virus VP35 are components of the nucleocapsid complex; second, VP35 is essential for replication and transcription of both viruses; third, interaction between NP and VP35 (first and second gene product) parallels interaction between N (NP) and P of paramyxo-, rhabdo-, and borna viruses. It is therefore proposed to further designate VP35 of the Filoviridae as P(Muhlberger et al., 1999). Transcription by the viral RNA-dependent RNA polymerase initiates at the 3' end of the genome, resulting in synthesis of a leader RNA and seven polyadenylated mRNAs. Accumulation of the first two proteins encoded at the 3' end of the genome (NP and VP35) in some way triggers a switch to production of full-length, positive-sense `antigenomes', which serve, in turn, as templates for genome synthesis (Bray and Paragas, 2002).Recent studies have demonstrated that cotransfection of 293T cells with NP, VP35, and VP24 supported capsid formation, and omission of any one of these three genes abolished the effect, demonstrating that they are necessary and sufficient for viral particle formation (Huang et al., 2002).(<a href="#reference5369">Muhlberger et al., 1999</a>)(<a href="#reference5377">Bray et al., 2002</a>)(<a href="#reference5378">Huang et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_409">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP40 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Between the nucleocapsid and the viral envelope, Marburg virus particles contain two proteins, VP24 and the highly abundant VP40, whose function is not yet elucidated. However, the position of VP40 in the genome (third gene), its hydrophobicity, and its abundance within the virions suggest that VP40 represents a homologue of the matrix proteins of other nonsegmented negative-strand RNA viruses (Kolesnikova et al., 2002).  VP40 has been identified in viral inclusions, associated with individual nucleocapsids, and in the foci of viral budding. Additionally, VP40 has been detected in clusters of intracellular membranes and in plasma membrane protrusions. When the localization of recombinant VP40 was investigated, it was found to be firmly associated with membrane structures that have several characteristics of late endosomal compartment. Data indicate that Marburg virus VP40 is able to interact with membranes of the late endosomal compartment independently of other viral proteins (Kolesnikova et al., 2002).(<a href="#reference5370">Kolesnikova et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_410">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pre-GP protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Two hydrophobic regions have been identified in GP, one at the N-terminus, the other in the C-terminal region.  The N-terminal hydrophobic region is not present in the mature protein, indicating that this region serves as a signal peptide.  The C-terminal hydrophobic domain is used as a membrane anchor which is adjacent to the short cytoplasmic tail constituted by the last eight amino acids of the protein.  Two fatty acid attachment sites were identified at the boundary between membrane anchor and cytoplasmic domain.  GP is heavily N- and O-glycosylated containing 19 potential N-linked glycosylation sites and several clusters of hydroxyamino acids which serve as O-linked glycosylation sites (Sanger et al., 2002).(<a href="#reference5371">Sanger et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_411">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP30 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The Marburg virus nucleocapsid complex is composed of four viral proteins (NP, L, VP35, and VP30) and the negative-strand nonsegmented genomic RNA. NP, L, and VP35 are functionally conserved among the order Mononegavirales, whereas VP30, a phosphoprotein, represents a filovirus-specific nucleocapsid protein (Modrof et al., 2001).  Phosphorylation of serine residues 40 and 42 is essential for the interaction of the protein with the aggregates of NP, which are built of nucleocapsid-like particles.  This interaction is presumed to stand for one step in the maturation of the Marburg virus nucleocapsid (Modrof et al., 2001).(<a href="#reference5379">Modrof et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_412">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP24 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Between the nucleocapsid and the viral envelope, Marburg virus particles contain two proteins, VP24 and the highly abundant VP40, whose function is not yet elucidated (Kolesnikova et al., 2002).(<a href="#reference5370">Kolesnikova et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_413">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">L protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Enzyme.
Three of the four nucleocapsid proteins, NP, VP35, and L, are sufficient to support replication and transcription of an Marburg virus-specific monocistronic minigenome (Muhlberger et al., 1999).  L (encoded by the last gene) is present in nucleocapsids only in catalytic amounts corresponding to its presumed function as RNA-dependent RNA polymerase (Becker and Muhlberger, 1999).  As with other negative-strand RNA viruses, the RNA-dependent RNA polymerase of filoviruses is the largest and least abundant viral protein in both the virion and in infected cells (Peters et al., 1996).(<a href="#reference5369">Muhlberger et al., 1999</a>)(<a href="#reference5382">Becker</a>)(<a href="#reference5384">Peters</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_414">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pre-GP protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Endoplasmic_reticulum"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
GP is synthesized at the rough endoplasmic reticulum as a precursor of 140 kDa, which carries N-linked sugar side chains from the high mannose type (Sanger et al., 2002).(<a href="#reference5371">Sanger et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_415">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pre-GP protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
GP is transported to the Golgi apparatus where high mannose N-linked sugar side chains are modified to the complex type and, additionally, O-linked carbohydrates are attached (Sanger et al., 2002).  New evidence shows that GP is phosphorylated in the Golgi apparatus before the protein reaches the trans-Golgi network (Sanger et al., 2002).   As a late step of maturation, GP is cleaved by the prohormone convertase furin in the trans-Golgi network.  The precursor, GP0, gives rise to two fragment, GP1 and GP2, which are connected by disulfide linkages (Sanger et al., 2002).(<a href="#reference5371">Sanger et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_416">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GP1 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The precursor, GP0, gives rise to two fragments, GP1 and GP2, which are connected by disulfide linkages (Sanger et al., 2002).(<a href="#reference5371">Sanger et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_417">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GP2 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The precursor, GP0, gives rise to two fragments, GP1 and GP2, which are connected by disulfide linkages (Sanger et al., 2002).  GP2 contains a sequence of several, uncharged hydrophobic amino acids at a distance of 22 (Ebola virus) or 91 (Marburg virus) amino acids from the cleavage site and which bears some structural similarity to the fusion peptides of retroviruses (Feldmann et al., 2001).(<a href="#reference5371">Sanger et al., 2002</a>)(<a href="#reference5376">Feldmann et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_418">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GP1/2 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
A special arrangement of cysteine residues in the GP1/2 molecules allows the formation of an intramolecular disulphide bridge between the two cleavage products.  This suggests a stem region consisting of GP1 and GP2 and a crown-like domain on the top formed by GP1 that carries the mass of the carbohydrate side chains.  The mature transmembrane glycoprotein is a trimer comprising disulphide-bonded GP1/2 molecules.  The mature transmembrane glycoprotein forms spikes without the need for other viral proteins (Feldmann et al., 2001).GP is vectorially transported, mainly to the apical membrane compartment (Sanger et al., 2001).(<a href="#reference5376">Feldmann et al., 2001</a>)(<a href="#reference5371">Sanger et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_419">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GP1/2 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cell_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The mature envelope glycoprotein GP1/2 is anchored in the membrane by a carboxy-terminal hydrophobic domain of GP2. The middle region of GP1/2 is variable, extremely hydrophilic and carries the bulk of N- and O-glycans, which account for more than one-third of the molecular mass of the mature protein. Oligosaccharide side chains differ in their terminal sialylation patterns. Two carboxy-terminal cysteine residues are acylated. GP2 contains a sequence of several uncharged, hydrophobic amino acids at a distance of 22 (Ebola virus) or 91 (Marburg virus) amino acids from the cleavage site and which bears some structural similarity to the fusion peptides of retroviruses.  The special arrangement of the cysteine residues in the GP1/2 molecules allows the formation of an intramolecular disulphide bridge between the two cleavage products. This suggests a stem region consisting of GP1 and GP2 and a crown-like domain on the top formed by GP1 that carries the mass of the carbohydrate side chains. It can be assumed that cysteine residue 53 is also critical for maintaining the structure of GP1/2. The mature transmembrane glycoprotein is a trimer comprising disulphide-bonded GP1/2 molecules (Feldmann et al., 2001).  The mature form of GP is efficiently transported to the plasma membrane (Becker et al., 1996). GP is vectorially transported, mainly to the apical membrane compartment (Sanger et al., 2001).(<a href="#reference5376">Feldmann et al., 2001</a>)(<a href="#reference5375">Sanger et al., 2001</a>)(<a href="#reference5381">Becker et al., 1996</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_420">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GP protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
GP is shed from the apical membrane into the medium. Shedding of GP is also detected with Ebola virus, where the protein is found in large quantities in the supernatant of infected cells. The role of shed GP molecules, either soluble or incorporated into virosomes, in the course of Marburg or Ebola hemorrhagic fever is not yet understood (Sanger et al., 2001).(<a href="#reference5375">Sanger et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_421">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Viral capsid</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The assembly of new viral particles occurs on the inner surface of the plasma membrane, where VP24 and VP40 apparently associate both with new RNPs and with the cytoplasmic tail of GP2 (Bray and Paragas, 2002).(<a href="#reference5377">Bray et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_422">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Budding virus</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cell_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Nascent virions become enveloped by the GP-bearing lipid bilayer and exit the cell through budding (Bray and Paragas, 2002).  New data demonstrate the compartmentalization of Ebola and Marburg viral proteins in lipid rafts during viral assembly and budding (Bavari et al., 2002).(<a href="#reference5377">Bray et al., 2002</a>)(<a href="#reference5380">Bavari et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_423">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Virion</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The complete replication cycle takes approximately 12 hours.  As for many other viruses, filovirus replication triggers a cascade of reactions in infected cells, including the de novo production of type I interferon (IFN-/), which collectively constitute the innate antiviral response. At the same time, certain viral proteins apparently suppress some of these antiviral mechanisms, giving the virus an advantage over its host.  The ability of filoviruses to overcome initial defensive barriers and rapidly disseminate may be an essential factor in their virulence  (Bray and Paragas, 2002).(<a href="#reference5377">Bray et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_424">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Furin</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Cleavage of GP into GP1 and GP2 was mediated by furin or another subtilisin-like endoprotease with similar substrate specificity (Volchkov et al., 2000).(<a href="#reference5374">Volchkov et al., 2000</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_425">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Furin</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Cleavage of GP into GP1 and GP2 was mediated by furin or another subtilisin-like endoprotease with similar substrate specificity (Volchkov et al., 2000).(<a href="#reference5374">Volchkov et al., 2000</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
